• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBJ060502
Device Problems Improper or Incorrect Procedure or Method (2017); Positioning Problem (3009)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 03/03/2014
Event Type  Injury  
Event Description
Patient presented with an in-stent restenosis.A 6fr introducer sheath was used to advance a 6x5 gore viabahn endoprosthesis over an.014 guidewire.The gore viabahn endoprosthesis was unable to reach the target site.The deployment line got hung up on a stent strut.In the process of advancing the gore viabahn endoprosthesis, the iliac artery was perforated.The constrained gore viabahn endoprosthesis was removed through the introducer sheath and was discarded.A 7fr introducer sheath was used to advance a second (6x10) gore viabahn endoprosthesis over an.035 guidewire to treat the perforated vessel.Some bleeding was observed after the gore viabahn endoprosthesis was deployed.The patient was transferred for an open surgical repair.
 
Manufacturer Narrative
Manufacturing report #2017233-2014-00165 was submitted for second device used during same procedure.Review of device manufacturing record history confirmed device met pre-release specifications.Warnings section of ifu states: w.L.Gore & associates has insufficient clinical and experimental data upon which to base any conclusions regarding the effectiveness of the gore viabahn endoprosthesis in applications where the device is deployed within stents or stent grafts other than the gore viabahn endoprosthesis.Other devices may interfere with the deployment of the gore viabahn endoprosthesis resulting in deployment failure or other device malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3715010
MDR Text Key4249529
Report Number2017233-2014-00164
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/31/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2016
Device Catalogue NumberVBJ060502
Device Lot Number11874007
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/21/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GORE VIABAHN ENDOPROSTHESIS, LOT 12060761
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-